Back to Results
First PageMeta Content
Chemistry / Business / Organic chemistry / Combination drugs / Ethers / Amines / Erlotinib / Pfizer / Quinazolines / Teva Pharmaceutical Industries / Atovaquone/proguanil / Novartis


Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016
Add to Reading List

Document Date: 2016-07-22 09:17:34


Open Document

File Size: 281,50 KB

Share Result on Facebook
UPDATE